Holen Sie sich die Stockscreener-App
694.25
1.59%
-11.19
Handel nachbörslich:
695.00
0.75
+0.11%
Schlusskurs vom Vortag:
$705.44
Offen:
$694.98
24-Stunden-Volumen:
16.68M
Relative Volume:
0.95
Marktkapitalisierung:
$1.77T
Einnahmen:
$214.96B
Nettoeinkommen (Verlust:
$70.59B
KGV:
25.24
EPS:
27.5066
Netto-Cashflow:
$48.25B
1W Leistung:
-8.95%
1M Leistung:
+4.28%
6M Leistung:
+3.48%
1J Leistung:
-5.18%
1-Tages-Spanne:
$681.05
$696.50
1-Wochen-Bereich:
$681.05
$761.50
52-Wochen-Spanne:
$520.26
$779.82
Meta Platforms Inc Stock (META) Company Profile
Firmenname
Meta Platforms Inc
Sektor
Telefon
650-543-4800
Adresse
1 META WAY, MENLO PARK
Compare META vs GOOGL, GOOG, SPOT, RDDT
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
META
Meta Platforms Inc
|
694.25 | 1.77T | 214.96B | 70.59B | 48.25B | 27.51 |
GOOGL
Alphabet Inc
|
340.27 | 4.16T | 446.32B | 244.21B | 53.27B | 19.91 |
GOOG
Alphabet Inc
|
336.40 | 4.11T | 446.32B | 244.21B | 53.27B | 19.91 |
SPOT
Spotify Technology Sa
|
526.08 | 108.15B | 20.32B | 3.16B | 3.82B | 12.55 |
RDDT
Reddit Inc
|
155.65 | 29.95B | 2.47B | 707.54M | 868.73M | 3.5267 |
Meta Platforms Inc Stock (META) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-09-28 | Bestätigt | Monness Crespi & Hardt | Buy |
| 2026-09-25 | Bestätigt | Canaccord Genuity | Buy |
| 2026-09-25 | Bestätigt | Deutsche Bank | Buy |
| 2026-09-25 | Bestätigt | Piper Sandler | Overweight |
| 2026-09-25 | Bestätigt | TD Cowen | Buy |
| 2026-09-23 | Bestätigt | KeyBanc Capital Markets | Overweight |
| 2026-09-21 | Bestätigt | Wells Fargo | Overweight |
| 2026-09-10 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2026-08-27 | Bestätigt | Rosenblatt | Buy |
| 2026-08-27 | Bestätigt | Truist | Buy |
| 2026-07-30 | Bestätigt | Monness Crespi & Hardt | Buy |
| 2026-07-16 | Fortgesetzt | Wedbush | Neutral |
| 2026-07-10 | Bestätigt | Citizens | Mkt Outperform |
| 2026-07-07 | Hochstufung | Erste Group | Hold → Buy |
| 2026-06-02 | Hochstufung | Arete | Neutral → Buy |
| 2026-05-20 | Bestätigt | Wells Fargo | Overweight |
| 2026-05-05 | Bestätigt | Mizuho | Outperform |
| 2026-04-30 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2026-04-10 | Bestätigt | Wolfe Research | Outperform |
| 2026-04-09 | Bestätigt | Rosenblatt | Buy |
| 2026-04-02 | Herabstufung | Erste Group | Buy → Hold |
| 2026-03-30 | Bestätigt | Morgan Stanley | Overweight |
| 2026-03-05 | Herabstufung | Arete | Buy → Neutral |
| 2026-03-05 | Hochstufung | Erste Group | Hold → Buy |
| 2026-02-23 | Bestätigt | Wells Fargo | Overweight |
| 2026-01-29 | Bestätigt | Canaccord Genuity | Buy |
| 2026-01-29 | Bestätigt | Cantor Fitzgerald | Overweight |
| 2026-01-29 | Bestätigt | Deutsche Bank | Buy |
| 2026-01-29 | Bestätigt | Evercore ISI | Outperform |
| 2026-01-29 | Bestätigt | Guggenheim | Buy |
| 2026-01-29 | Bestätigt | JP Morgan | Overweight |
| 2026-01-29 | Bestätigt | Jefferies | Buy |
| 2026-01-29 | Bestätigt | KeyBanc Capital Markets | Overweight |
| 2026-01-29 | Bestätigt | Mizuho | Outperform |
| 2026-01-29 | Bestätigt | Monness Crespi & Hardt | Buy |
| 2026-01-29 | Bestätigt | Morgan Stanley | Overweight |
| 2026-01-29 | Bestätigt | Piper Sandler | Overweight |
| 2026-01-29 | Bestätigt | Pivotal Research Group | Buy |
| 2026-01-29 | Bestätigt | Robert W. Baird | Outperform |
| 2026-01-29 | Bestätigt | Roth Capital | Buy |
| 2026-01-29 | Bestätigt | Stifel | Buy |
| 2026-01-29 | Bestätigt | UBS | Buy |
| 2026-01-29 | Bestätigt | Wedbush | Outperform |
| 2026-01-29 | Bestätigt | Wells Fargo | Overweight |
| 2026-01-29 | Bestätigt | Wolfe Research | Outperform |
| 2026-01-26 | Bestätigt | KeyBanc Capital Markets | Overweight |
| 2026-01-26 | Bestätigt | Raymond James | Strong Buy |
| 2026-01-26 | Hochstufung | Rothschild & Co Redburn | Neutral → Buy |
| 2026-01-23 | Bestätigt | Stifel | Buy |
| 2026-01-13 | Bestätigt | TD Cowen | Buy |
| 2026-01-12 | Bestätigt | Wells Fargo | Overweight |
| 2026-01-08 | Bestätigt | Cantor Fitzgerald | Overweight |
| 2026-01-08 | Bestätigt | Guggenheim | Buy |
| 2025-12-04 | Hochstufung | Arete | Neutral → Buy |
| 2025-11-24 | Eingeleitet | BNP Paribas Exane | Outperform |
| 2025-11-10 | Herabstufung | Erste Group | Buy → Hold |
| 2025-10-30 | Bestätigt | Barclays | Overweight |
| 2025-10-30 | Bestätigt | Bernstein | Outperform |
| 2025-10-30 | Bestätigt | BofA Securities | Buy |
| 2025-10-30 | Bestätigt | Citigroup | Buy |
| 2025-10-30 | Bestätigt | JP Morgan | Overweight |
| 2025-10-30 | Bestätigt | Jefferies | Buy |
| 2025-10-30 | Bestätigt | Mizuho | Outperform |
| 2025-10-30 | Bestätigt | Monness Crespi & Hardt | Buy |
| 2025-10-30 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2025-10-30 | Bestätigt | Piper Sandler | Overweight |
| 2025-10-30 | Bestätigt | Stifel | Buy |
| 2025-10-30 | Herabstufung | The Benchmark Company | Buy → Hold |
| 2025-10-20 | Bestätigt | Oppenheimer | Outperform |
| 2025-10-07 | Bestätigt | Wells Fargo | Overweight |
| 2025-09-30 | Eingeleitet | Mizuho | Outperform |
| 2025-07-31 | Bestätigt | BMO Capital Markets | Market Perform |
| 2025-07-31 | Bestätigt | Bernstein | Outperform |
| 2025-07-31 | Bestätigt | BofA Securities | Buy |
| 2025-07-31 | Bestätigt | Citigroup | Buy |
| 2025-07-31 | Bestätigt | Citizens JMP | Mkt Outperform |
| 2025-07-31 | Bestätigt | JP Morgan | Overweight |
| 2025-07-31 | Bestätigt | KeyBanc Capital Markets | Overweight |
| 2025-07-31 | Bestätigt | Monness Crespi & Hardt | Buy |
| 2025-07-31 | Bestätigt | Morgan Stanley | Overweight |
| 2025-07-31 | Bestätigt | Oppenheimer | Outperform |
| 2025-07-31 | Bestätigt | Pivotal Research Group | Buy |
| 2025-07-31 | Bestätigt | TD Cowen | Buy |
| 2025-07-31 | Bestätigt | UBS | Buy |
| 2025-07-31 | Bestätigt | Wedbush | Outperform |
| 2025-07-31 | Bestätigt | Wells Fargo | Overweight |
| 2025-07-28 | Bestätigt | Guggenheim | Buy |
| 2025-07-16 | Bestätigt | Canaccord Genuity | Buy |
| 2025-07-03 | Hochstufung | Needham | Underperform → Hold |
| 2025-06-26 | Bestätigt | UBS | Buy |
| 2025-06-24 | Bestätigt | Citigroup | Buy |
| 2025-05-01 | Bestätigt | BofA Securities | Buy |
| 2025-05-01 | Bestätigt | Citigroup | Buy |
| 2025-05-01 | Bestätigt | Evercore ISI | Outperform |
| 2025-05-01 | Bestätigt | Goldman | Buy |
| 2025-05-01 | Bestätigt | Guggenheim | Buy |
| 2025-05-01 | Bestätigt | JP Morgan | Overweight |
| 2025-05-01 | Bestätigt | KeyBanc Capital Markets | Overweight |
| 2025-05-01 | Bestätigt | MoffettNathanson | Buy |
| 2025-05-01 | Bestätigt | Monness Crespi & Hardt | Buy |
| 2025-05-01 | Bestätigt | Morgan Stanley | Overweight |
| 2025-05-01 | Bestätigt | Oppenheimer | Outperform |
| 2025-05-01 | Bestätigt | Piper Sandler | Overweight |
| 2025-05-01 | Bestätigt | Pivotal Research Group | Buy |
| 2025-05-01 | Bestätigt | Raymond James | Strong Buy |
| 2025-05-01 | Bestätigt | Rosenblatt | Buy |
| 2025-05-01 | Bestätigt | Roth Capital | Buy |
| 2025-05-01 | Bestätigt | Stifel | Buy |
| 2025-05-01 | Bestätigt | Truist | Buy |
| 2025-05-01 | Bestätigt | UBS | Buy |
| 2025-05-01 | Bestätigt | Wedbush | Outperform |
| 2025-04-14 | Bestätigt | Citigroup | Buy |
| 2025-04-10 | Bestätigt | Piper Sandler | Overweight |
| 2025-01-30 | Hochstufung | The Benchmark Company | Hold → Buy |
| 2025-01-23 | Bestätigt | BofA Securities | Buy |
| 2025-01-22 | Bestätigt | Cantor Fitzgerald | Overweight |
| 2025-01-06 | Bestätigt | Jefferies | Buy |
| 2025-01-03 | Bestätigt | Wolfe Research | Outperform |
| 2024-10-31 | Bestätigt | Monness Crespi & Hardt | Buy |
| 2024-10-31 | Bestätigt | Pivotal Research Group | Buy |
| 2024-10-11 | Eingeleitet | Scotiabank | Sector Perform |
| 2024-10-09 | Bestätigt | Cantor Fitzgerald | Overweight |
| 2024-10-01 | Eingeleitet | Pivotal Research Group | Buy |
| 2024-09-30 | Bestätigt | Monness Crespi & Hardt | Buy |
| 2024-09-10 | Eingeleitet | DA Davidson | Buy |
| 2024-09-05 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2024-08-01 | Bestätigt | BofA Securities | Buy |
| 2024-07-19 | Bestätigt | Oppenheimer | Outperform |
| 2024-07-16 | Eingeleitet | Wolfe Research | Outperform |
| 2024-07-10 | Bestätigt | TD Cowen | Buy |
| 2024-07-08 | Bestätigt | Wells Fargo | Overweight |
| 2024-07-01 | Bestätigt | Raymond James | Strong Buy |
| 2024-06-12 | Bestätigt | BMO Capital Markets | Market Perform |
| 2024-05-02 | Eingeleitet | Exane BNP Paribas | Underperform |
| 2024-04-25 | Bestätigt | Oppenheimer | Outperform |
| 2024-04-15 | Bestätigt | Citigroup | Buy |
| 2024-04-11 | Bestätigt | Piper Sandler | Overweight |
| 2024-04-08 | Bestätigt | Oppenheimer | Outperform |
| 2024-04-04 | Bestätigt | Jefferies | Buy |
| 2024-02-02 | Bestätigt | Guggenheim | Buy |
| 2024-02-02 | Bestätigt | JMP Securities | Mkt Outperform |
| 2024-02-02 | Bestätigt | JP Morgan | Overweight |
| 2024-02-02 | Bestätigt | KeyBanc Capital Markets | Overweight |
| 2024-02-02 | Bestätigt | Mizuho | Buy |
| 2024-02-02 | Bestätigt | Monness Crespi & Hardt | Buy |
| 2024-02-02 | Bestätigt | Morgan Stanley | Overweight |
| 2024-02-02 | Bestätigt | Oppenheimer | Outperform |
| 2024-02-02 | Bestätigt | Piper Sandler | Overweight |
| 2024-02-02 | Bestätigt | ROTH MKM | Buy |
| 2024-02-02 | Bestätigt | Raymond James | Strong Buy |
| 2024-02-02 | Bestätigt | Robert W. Baird | Outperform |
| 2024-02-02 | Bestätigt | Seaport Research Partners | Buy |
| 2024-02-02 | Bestätigt | Stifel | Buy |
| 2024-02-02 | Bestätigt | Susquehanna | Positive |
| 2024-02-02 | Bestätigt | TD Cowen | Outperform |
| 2024-02-02 | Bestätigt | UBS | Buy |
| 2024-02-02 | Bestätigt | Wedbush | Outperform |
| 2024-02-02 | Bestätigt | Wells Fargo | Overweight |
| 2024-02-02 | Bestätigt | Wolfe Research | Outperform |
| 2024-01-23 | Bestätigt | Citigroup | Buy |
| 2024-01-17 | Bestätigt | Piper Sandler | Overweight |
| 2024-01-17 | Bestätigt | Wells Fargo | Overweight |
| 2024-01-09 | Eingeleitet | BMO Capital Markets | Market Perform |
| 2023-12-20 | Fortgesetzt | Raymond James | Strong Buy |
| 2023-10-24 | Eingeleitet | Seaport Research Partners | Buy |
| 2023-08-22 | Eingeleitet | Wedbush | Outperform |
| 2023-08-01 | Bestätigt | Argus | Buy |
| 2023-07-28 | Hochstufung | China Renaissance | Hold → Buy |
| 2023-07-27 | Hochstufung | HSBC Securities | Reduce → Hold |
| 2023-07-27 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2023-07-25 | Bestätigt | Mizuho | Buy |
| 2023-07-25 | Hochstufung | New Street | Neutral → Buy |
| 2023-07-19 | Bestätigt | Jefferies | Buy |
| 2023-07-19 | Bestätigt | Truist | Buy |
| 2023-07-17 | Bestätigt | Credit Suisse | Outperform |
| 2023-07-17 | Bestätigt | Goldman | Buy |
| 2023-07-17 | Bestätigt | JMP Securities | Mkt Outperform |
| 2023-07-13 | Hochstufung | TD Cowen | Market Perform → Outperform |
| 2023-07-12 | Bestätigt | Deutsche Bank | Buy |
| 2023-06-08 | Eingeleitet | Wells Fargo | Equal Weight |
| 2023-05-15 | Hochstufung | Loop Capital | Hold → Buy |
| 2023-04-27 | Bestätigt | Credit Suisse | Outperform |
| 2023-04-27 | Bestätigt | Deutsche Bank | Buy |
| 2023-04-27 | Bestätigt | Evercore ISI | Outperform |
| 2023-04-27 | Bestätigt | Goldman | Buy |
| 2023-04-27 | Bestätigt | Guggenheim | Buy |
| 2023-04-27 | Bestätigt | JMP Securities | Mkt Outperform |
| 2023-04-27 | Bestätigt | JP Morgan | Overweight |
| 2023-04-27 | Bestätigt | Mizuho | Buy |
| 2023-04-27 | Bestätigt | Monness Crespi & Hardt | Buy |
| 2023-04-27 | Bestätigt | Morgan Stanley | Overweight |
| 2023-04-27 | Bestätigt | Oppenheimer | Outperform |
| 2023-04-27 | Bestätigt | Piper Sandler | Overweight |
| 2023-04-27 | Bestätigt | RBC Capital Mkts | Outperform |
| 2023-04-27 | Bestätigt | Raymond James | Outperform |
| 2023-04-27 | Bestätigt | Robert W. Baird | Outperform |
| 2023-04-27 | Bestätigt | Rosenblatt | Buy |
| 2023-04-27 | Bestätigt | Stifel | Buy |
| 2023-04-27 | Bestätigt | TD Cowen | Market Perform |
| 2023-04-27 | Bestätigt | Truist | Buy |
| 2023-04-27 | Bestätigt | Wolfe Research | Outperform |
Alle ansehen
Meta Platforms Inc Aktie (META) Neueste Nachrichten
Better Nuclear Energy Stock to Buy After the Sell-Off: Oklo vs. X-Energy - The Motley Fool
AGI Is Almost Ready. Is Your Portfolio? - The Motley Fool
AI Stock Sell-Off: Are Mag 7 Stocks Still Buys? ETFs in Focus - Zacks Investment Research
Form 4 Meta Platforms Inc For: 20 October By Investing.com - Investing.com UK
Nvidia Stock Hasn’t Been This Cheap in 7 Years. Only 1 Explanation Makes Sense. - The Motley Fool
Should You Buy Meta Stock Before the Huge Investor Update? - The Motley Fool
Prediction: Oct. 21 Will Be a Huge Day for the Stock Market - The Motley Fool
Up 10% in the Last Two Weeks, Is Airbnb the Perfect Stock for Today's Market? - The Motley Fool
Thinking Nvidia Stock Could Hit $10 Trillion? Here's 1 Reason I'd Be Cautious - The Motley Fool
Form 144 Meta Platforms For: 19 October By Investing.com - Investing.com Australia
5 Must-See Earnings Charts This Week - Zacks Investment Research
Form 144 Meta Platforms For: 19 October By Investing.com - Investing.com India
Dario Amodei Predicted at Davos in January 2025 That AI Could Surpass Humans "at Almost Everything" Within Two to Three Years. With Anthropic Now Filing for a $2 Trillion IPO, Is That Timeline Still on Track? - The Motley Fool
Anthropic IPO, MANGOS ETFs and the Future of the AI Trade - Zacks Investment Research
Here's What a $5,000 Investment in AMD Could Be Worth by 2032 - The Motley Fool
Nebius and 3 Other Stocks I Don't Mind Buying Before 2026 Ends - The Motley Fool
Stock Market Midday, Oct. 19: Tech Stocks Rebound as AI Confidence Returns - The Motley Fool
Breakfast News: Power Is AI’s New Gold Rush - The Motley Fool
Not Nvidia. Not Micron. This Artificial Intelligence (AI) Chip Stock Has the Most Upside Through 2030. - The Motley Fool
Pre-Market Indexes Mixed - Zacks Investment Research
Pre-Markets Mixed Ahead of New Q3 Earnings, Housing Data - Zacks Investment Research
Meta, Tesla, Nvidia, Micron and Alphabet are part of Zacks Earnings Preview - Zacks Investment Research
Breakfast News: Power Is AI’s New Gold Rush - The Motley Fool
Will AI Companies Generate Enough Revenue to Continue the Build-Out? Here's What Nvidia CEO Jensen Huang Says. - The Motley Fool
Form 4 Alphabet Inc Class A For: 19 October By Investing.com - Investing.com Canada
The Trillion-Dollar AI Bet: What It Means for Hyperscaler Investors - The Motley Fool
Should You Buy, Sell, or Hold META Stock Before Q3 Earnings Release? - Zacks Investment Research
Nebius Stock Has Fallen About 40% From Its Record. Here's Why I'm Still Waiting to Buy. - The Motley Fool
History Says Nvidia Stock Does This in November. Here's the 1 Thing That Could Break the Pattern. - The Motley Fool
President Trump Sells Micron Stock and Buys Another Mega-Cap Artificial Intelligence (AI) Stock - The Motley Fool
CoreWeave Is Projected to Have a 6.3x Gross Leverage Ratio by Year End. The Market Is Worried About the Neocloud's Balance Sheet. - The Motley Fool
1 Red Flag That AMD Investors Should Be Aware Of Now - The Motley Fool
Here's What $10,000 Invested in Broadcom Will Be Worth by 2028 - The Motley Fool
AI’s Power Problem Just Got a Number: 32 Gigawatts - GlobeNewswire Inc.
Competing for Eyeballs: Can Pinterest Stage a Comeback or Will Reddit Run Away With the AI Win? - The Motley Fool
Once-in-a-Decade Buying Opportunity: This AI Stock That’s Soared 900% Over 5 Years Is the Cheapest of the “Magnificent Seven.” - The Motley Fool
AI Debt Warning Signs Are Piling Up: Why Bond Markets Are Getting Nervous About AI Infrastructure Spending - The Motley Fool
Bloom Energy vs. Constellation Energy: Which Energy Stock Is an AI-Driven Buy in 2026? - The Motley Fool
Q3 Earnings Season Preview: Revenue Beats Lag, Multi-Sector Momentum Holds - Zacks Investment Research
Inflation Pressures Rise as Services Activity Weakens - Zacks Investment Research
First Week of Q3 Earnings in the Books - Zacks Investment Research
This Unstoppable Vanguard ETF Could Turn $500 Per Month Into $1 Million Over the Long Term - The Motley Fool
The Stock Market Is Doing Something for Only the 3rd Time in 156 Years, and History Is Clear a Crash May be Hiding in Plain Sight - The Motley Fool
Cathie Wood Is Buying Shares of This Bargain “Magnificent Seven” Stock Before Oct. 21. Should You? - The Motley Fool
Form 4 Meta Platforms Inc For: 16 October By Investing.com - Investing.com UK
CoreWeave Stock Is Crashing. This Could Be Great News for SpaceX Investors. - The Motley Fool
This Dividend King Is Getting In on the AI Energy Boom With Its Recent Deal with Google. Is It a Buy? - The Motley Fool
Billionaires Are Selling These 6 Artificial Intelligence (AI) Stocks. Should You Follow? - The Motley Fool
Prediction: A $10,000 Investment in This Artificial Intelligence (AI) Hardware Stock Will At Least Double by 2030 (Hint: It’s Not Nvidia or Micron) - The Motley Fool
SpaceX Has Climbed 15% From Its IPO Price. Here’s Where History Says It Will Be After 1 Year. - The Motley Fool
Finanzdaten der Meta Platforms Inc-Aktie (META)
Umsatz
Nettogewinn
Free Cashflow
ENV
Meta Platforms Inc-Aktie (META) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Olivan Javier | Chief Operating Officer |
Oct 12 '26 |
Sale |
728.10 |
629 |
457,975 |
1,004 |
| Olivan Javier | Officer |
Oct 12 '26 |
Proposed Sale |
728.10 |
1,575 |
1,146,757 |
0 |
| Olivan Javier | Chief Operating Officer |
Oct 12 '26 |
Sale |
728.10 |
946 |
688,783 |
6,932 |
| Olivan Javier | Chief Operating Officer |
Oct 05 '26 |
Sale |
728.08 |
946 |
688,764 |
7,878 |
| Olivan Javier | Officer |
Oct 05 '26 |
Proposed Sale |
728.08 |
1,575 |
1,146,726 |
0 |
| Olivan Javier | Chief Operating Officer |
Oct 05 '26 |
Sale |
728.08 |
629 |
457,962 |
1,061 |
| Olivan Javier | Chief Operating Officer |
Sep 28 '26 |
Sale |
748.91 |
629 |
471,064 |
1,118 |
| Olivan Javier | Officer |
Sep 28 '26 |
Proposed Sale |
749.82 |
1,575 |
1,180,966 |
0 |
| Olivan Javier | Chief Operating Officer |
Sep 28 '26 |
Sale |
750.42 |
946 |
709,902 |
8,824 |
| Zuckerberg Mark | Officer |
Sep 24 '26 |
Proposed Sale |
777.44 |
27,474 |
21,359,454 |
0 |
1.41%
1.15%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):